UCSF CLINICAL RESEARCH CURRICULUM AWARD

描述(由申请人提供)： 自1999年获得我们的第一个K30奖项以来，加州大学旧金山分校的临床研究培训计划(TICR)朝着我们增加临床研究人员的数量、多样性和质量的目标取得了很大进展。通过我们修订和扩大的8周临床研究研讨会，我们正式的1年期临床研究高级培训证书计划，以及我们新的2年期临床研究硕士学位计划，在过去5年中，我们培训了700多名新的临床研究人员。这包括将加州大学旧金山分校的正式课程数量从2门增加到24门；创建一种结构化的指导方法；通过发布广泛使用的文本和创建一个开放访问网站来传播我们的教学方法；以及使用学生评估和同行的建议来不断改进我们的战略和表现。我们的理念是邀请学生创建参与临床研究的实际产品：例如，对于我们的基石临床研究研讨会，每位学者为实际研究设计一份方案；对于我们的硕士学位，他/她设计、实施、分析、提交并提交临床研究报告以供发表。 在接下来的5年里，我们计划继续所有这些成功的计划和战略，并以多种方式加强和扩展它们。我们正在开发两个新的学位项目：与加州大学伯克利分校公共卫生学院的联合博士学位，以及为加州大学旧金山分校医学生提供的新的5年制医学硕士学位选项。我们计划对现有的每门课程进行改进，并将开设6门新课程，其中包括遗传流行病学和统计遗传学的四分之三系列。我们的目标是将每年录取的硕士研究生人数增加一倍(N=20人)，特别注意增加来自加州大学旧金山分校不具代表性的院系和种族背景的人数。我们将为学者创造一个观察和讨论IRB如何运作的机会，并开始要求MCR候选人口头为他们的论点辩护，并向他们的委员会展示方法掌握。我们计划创新以加强指导和职业发展，包括为导师、每周研究诊所和半年一次的职业发展论坛提供结构化指导。一些新的教材正在编写中，我们将采取措施，增加其他机构对我们教材的使用。新的焦点小组、离职面谈和校友聚会将加强我们的评估过程，我们将利用这些信息和来自内部和外部咨询委员会以及其他K30项目同事的建议来持续努力改进我们的计划。

DESCRIPTION (provided by applicant): Since receiving our first K30 award in 1999, the UCSF Training In Clinical Research program (TICR) has made great progress toward our goal of increasing the number, diversity and quality of clinical investigators. Through our revised and expanded 8-week Clinical Research Workshop, our formalized 1-year Advanced Training in Clinical Research Certificate Program, and our new 2-year Master's in Clinical Research Degree Program, we have trained over 700 new clinical researchers during the last 5 years. This has involved increasing the number of formal UCSF courses from 2 to 24; creating a structured approach to mentoring; disseminating our teaching methods by publishing widely-used texts and creating an open-access website; and using student evaluations and advice from peers to continuously improve our strategies and performance. Our philosophy is to invite students to create the actual products involved in clinical research: For our cornerstone Clinical Research Workshop, for example, each scholar designs a protocol for an actual study; for our Master's Degree she/he designs, conducts, analyzes, presents and submits for publication a clinical research study. During the next 5 years, we plan to continue all these successful programs and strategies, and to enhance and expand on them in a number of ways. We are developing 2 new degree programs: a joint PhD with the UC Berkeley School of Public Health, and a new 5-year MD-Master's Degree option for UCSF medical students. We plan improvements in each of our existing courses, and we will create 6 new courses including a 3-quarter series in genetic epidemiology and statistical genetics. We aim to double the number of master's scholars matriculating each year (to N=20), with particular attention to increasing the numbers from underrepresented UCSF departments and racial backgrounds. We will create an opportunity for scholars to observe and discuss how an IRB operates, and begin requiring MCR candidates to orally defend their thesis and demonstrate methodological mastery to their Committee. We plan innovations to enhance mentoring and career development including structured guidance for mentors, weekly research clinics, and semiannual career development forums. Several new texts are in progress, and we will take steps to increase the use of our teaching materials by other institutions. New focus groups, exit interviews, and alumni reunions will enhance our evaluation process, and we will use this information and advice from internal and external advisory committees and colleagues at other K30 programs in an ongoing 9 effort to improve our program.